Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.8 - $1.13 $2,840 - $4,012
-3,551 Reduced 97.26%
100 $0
Q1 2023

May 12, 2023

SELL
$0.86 - $1.82 $3,219 - $6,814
-3,744 Reduced 50.63%
3,651 $4,000
Q4 2022

Feb 08, 2023

BUY
$0.93 - $1.2 $3,742 - $4,828
4,024 Added 119.37%
7,395 $6,000
Q3 2022

Nov 10, 2022

SELL
$0.0 - $1.57 $0 - $5,374
-3,423 Reduced 50.38%
3,371 $4,000
Q2 2022

Aug 10, 2022

BUY
$0.0 - $0.01 $0 - $17
1,736 Added 34.32%
6,794 $8,000
Q1 2022

May 16, 2022

BUY
$0.0 - $0.0 $0 - $0
381 Added 8.15%
5,058 $10,000
Q4 2021

Feb 14, 2022

BUY
$0.0 - $0.01 $0 - $46
4,602 Added 6136.0%
4,677 $9,000
Q3 2021

Nov 15, 2021

SELL
$0.0 - $0.01 $0 - $34
-3,408 Reduced 97.85%
75 $0
Q2 2021

Aug 13, 2021

BUY
$0.0 - $0.02 $0 - $49
2,486 Added 249.35%
3,483 $14,000
Q1 2021

May 12, 2021

SELL
$0.0 - $0.01 $0 - $18
-1,833 Reduced 64.77%
997 $4,000
Q4 2020

Feb 11, 2021

BUY
$0.0 - $0.0 $0 - $0
2,755 Added 3673.33%
2,830 $10,000
Q3 2020

Nov 12, 2020

SELL
$0.0 - $0.0 $0 - $0
-6,014 Reduced 98.77%
75 $0
Q2 2020

Jul 31, 2020

BUY
$0.0 - $0.0 $0 - $0
6,014 Added 8018.67%
6,089 $14,000
Q1 2020

May 01, 2020

SELL
$0.0 - $0.0 $0 - $0
-250 Reduced 76.92%
75 $0
Q4 2019

Feb 14, 2020

SELL
$0.0 - $0.0 $0 - $0
-3,192 Reduced 90.76%
325 $1,000
Q3 2019

Nov 14, 2019

BUY
$0.0 - $0.0 $0 - $0
3,517 New
3,517 $7,000

About GENETIC TECHNOLOGIES LTD


  • Ticker GENE
  • Exchange OTC
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 15,389,900
  • Market Cap $19.1M
  • Description
  • Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...
More about GENE
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.